Neurological soft signs in Fibromyalgia.

Creative Commons License

Baydoğan Tan B. G., Tan S., Boran H. E., Günendi Z.

Uluslararası Katılımlı Türk Romatoloji Kongresi 8-12 Mart 2023, , Antalya, Türkiye, 8 - 12 Mart 2023, ss.59

  • Yayın Türü: Bildiri / Özet Bildiri
  • Basıldığı Şehir: Antalya
  • Basıldığı Ülke: Türkiye
  • Sayfa Sayıları: ss.59
  • Gazi Üniversitesi Adresli: Evet

Özet

Objective—To assess neurological soft signs (NSS) in individuals with fibromyalgia

syndrome (FMS) and to evaluate its relationship with disease severity.

Methods—Patients with FMS (n=30) and healthy controls (n=30) underwent systematic

neurological examination and assessment of NSS with Neurological Evaluation Scale (NES)

by a neurologist blinded to disease status. We obtained demographic and clinical data from

volunteers. Fibromyalgia Impact Questionnaire (FIQ) was used to determine impact of the

disease and Widespread Pain Index (WPI) and Symptom Severity Scale (SSS) were used to

determine disease severity in patients with FMS. We examined the correlation between NSS

and disease severity within the FMS group

Results—Compared to the control group, the FMS group had significantly more NSS total

score and scores of sequencing of complex motor acts (SCMA), sensory integration (SI),

motor coordination (MC) and other areas. FIQ and the disease duration of the FMS group

were not correlated with all of NES scores. WPI and SSS were correlated with NES total

score (p= 0,031 r= 0,394 p=0,026 r=0,406) and MC score (p= 0,042 r= 373 p=0,047 r=0,366)

but were not correlate scores of SCMA, SI and other areas.

Conclusions— This study shows that NSS are common in patients with FM, possibly due to

central sensitization and brain fokal gray matter abnormalities. The total NSS score correlated

with symptom severity but not correlated with the impact of disease in patients with FMS.